F270-0470 Screening compound: 2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}-N-[(pyridin-2-yl)methyl]acetamide

F270-0470 Screening compound: 2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}-N-[(pyridin-2-yl)methyl]acetamide
F270-0470 Screening compound: 2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}-N-[(pyridin-2-yl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F270-0470
2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}-N-[(pyridin-2-yl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F270-0470

Molecular Formula

C15H15N5O3 (C15 H15 N5 O3)

Compound Name

2-{3,4-dimethyl-7-oxo-6H,7H-[1,2]oxazolo[3,4-d]pyridazin-6-yl}-N-[(pyridin-2-yl)methyl]acetamide

IUPAC name

2-{34-dimethyl-7-oxo-6H7H-[12]oxazolo[34-d]pyridazin-6-yl}-N-[(pyridin-2-yl)methyl]acetamide

SMILES

Cc(onc12)c2C(C)=NN(CC(NCc2ncccc2)=O)C1=O

InChI

InChI=1S/C15H15N5O3/c1-9-13-10(2)23-19-14(13)15(22)20(18-9)8-12(21)17-7-11-5-3-4-6-16-11/h3-6H,7-8H2,1-2H3,(H,17,21)

InChI Key

FFJPTTMONPWHPA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27111139

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

313.32

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.160

Distribution Coefficient, logD

0.159

Water Solubility, LogSw

-1.73

Polar Surface Area

82.977

Acid Dissociation Constant (pKa)

13.40

Base Dissociation Constant (pKb)

4.74

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.70

F270-0470 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F270-0470 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F270-0470?
Check Price and Availability of F270-0470, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F270-0470 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F270-0470
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F270-0470
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F270-0470 available by request